In addition, ERK can be constitutively activated in leukemic progenitor cells [26], and inhibition of MEK/ERK signaling leading to apoptosis of AML cells may be a therapeutic remedy in the treatment of leukemia. This evidence concerns the gene MAP2K7 and acute myeloid leukemia.